应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TMO 赛默飞世尔
交易中 05-06 12:10:28 EDT
573.74
+1.36
+0.24%
最高
576.39
最低
570.35
成交量
27.06万
今开
573.87
昨收
572.38
日振幅
1.06%
总市值
2,190亿
流通市值
2,185亿
总股本
3.82亿
成交额
1.56亿
换手率
0.07%
流通股本
3.81亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
手术设备需求强劲,百通迪金森上调利润预期
Reuters · 05-02
手术设备需求强劲,百通迪金森上调利润预期
生物技术产品需求改善,Bio-Techne 第三季度业绩超出预期
Reuters · 05-01
生物技术产品需求改善,Bio-Techne 第三季度业绩超出预期
巴克莱:维持Thermo Fisher Scientific(TMO.US)评级
智通财经 · 04-26
巴克莱:维持Thermo Fisher Scientific(TMO.US)评级
赛默飞世尔2024财年第一财季实现净利润13.35亿美元,同比增加3.57%
自选股智能写手 · 04-26
赛默飞世尔2024财年第一财季实现净利润13.35亿美元,同比增加3.57%
BUZZ-街景:赛默飞 2024 年的 "设置看起来不错
Reuters · 04-25
BUZZ-街景:赛默飞 2024 年的 "设置看起来不错
BUZZ-赛默飞第一季度利润增长,上调全年利润预期
Reuters · 04-24
BUZZ-赛默飞第一季度利润增长,上调全年利润预期
赛默飞世尔盘中异动 股价大涨5.01%
自选股智能写手 · 04-24
赛默飞世尔盘中异动 股价大涨5.01%
赛默飞世尔科技公司 预计每股收益4.71美元 - 财报前瞻
Reuters · 04-22
赛默飞世尔科技公司 预计每股收益4.71美元 - 财报前瞻
高盛:维持Thermo Fisher Scientific(TMO.US)评级,由买入调整至买入评级, 目标价由550.00美元调整至640.00美元。
智通财经 · 04-10
高盛:维持Thermo Fisher Scientific(TMO.US)评级,由买入调整至买入评级, 目标价由550.00美元调整至640.00美元。
赛默飞世尔涨0.10% 股价突破600美元大关
自选股智能写手 · 03-12
赛默飞世尔涨0.10% 股价突破600美元大关
赛默飞世尔涨0.51% 股价突破600美元大关
自选股智能写手 · 03-08
赛默飞世尔涨0.51% 股价突破600美元大关
安捷伦第一季度业绩好于预期,股价上涨
Reuters · 02-28
安捷伦第一季度业绩好于预期,股价上涨
药物开发服务需求强劲,沃特世公司第四季度销售额超出预期
Reuters · 02-06
药物开发服务需求强劲,沃特世公司第四季度销售额超出预期
英国反垄断监管机构调查赛默飞世尔收购Olink的交易
新浪财经 · 02-02
英国反垄断监管机构调查赛默飞世尔收购Olink的交易
英国反垄断监管机构调查赛默飞世尔斥资 31 亿美元收购 Olink 的交易
Reuters · 02-02
英国反垄断监管机构调查赛默飞世尔斥资 31 亿美元收购 Olink 的交易
BUZZ-券商观点:尽管前景 "保守",赛默飞仍有望在 2024 年实现强劲增长
Reuters · 02-01
BUZZ-券商观点:尽管前景 "保守",赛默飞仍有望在 2024 年实现强劲增长
Revvity 2024 年销售额和利润均高于预期
Reuters · 02-01
Revvity 2024 年销售额和利润均高于预期
手术器械强劲增长,百通迪金森上调 2024 年利润预期
Reuters · 02-01
手术器械强劲增长,百通迪金森上调 2024 年利润预期
赛默飞世尔2023财年实现净利润59.95亿美元,同比减少13.74%
自选股智能写手 · 02-01
赛默飞世尔2023财年实现净利润59.95亿美元,同比减少13.74%
赛默飞世尔盘中异动 临近收盘急速下挫5.01%
自选股智能写手 · 02-01
赛默飞世尔盘中异动 临近收盘急速下挫5.01%
加载更多
公司概况
公司名称:
赛默飞世尔
所属市场:
NYSE
上市日期:
--
主营业务:
赛默飞世尔科技公司是一家特拉华州公司。该公司在为科学服务方面处于世界领先地位。该公司的使命是让客户让世界变得更健康、更清洁、更安全。该公司为在制药和生物技术公司、医院和临床诊断实验室、大学、研究机构和政府机构以及环境、工业、研发、质量和过程控制环境中工作的客户提供服务。该公司的全球团队通过行业领先品牌,包括Thermo Scientific、Applied Biosystems、Invitrogen、Fisher Scientific、Unity Lab Services、Patheon和PPD,提供无与伦比的创新技术、购买便利和制药服务组合。
发行价格:
--
{"stockData":{"symbol":"TMO","market":"US","secType":"STK","nameCN":"赛默飞世尔","latestPrice":573.74,"timestamp":1715011828275,"preClose":572.38,"halted":0,"volume":270648,"delay":0,"floatShares":380822610,"shares":381716323,"eps":15.594521,"marketStatus":"交易中","marketStatusCode":2,"change":1.36,"latestTime":"05-06 12:10:28 EDT","open":573.87,"high":576.385,"low":570.345,"amount":155504299.7592,"amplitude":0.010552,"askPrice":573.46,"askSize":8,"bidPrice":573.05,"bidSize":8,"shortable":3,"etf":0,"ttmEps":15.594521,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1715025600000},"adr":0,"listingDate":315550800000,"adjPreClose":572.38,"adrRate":0,"dividendRate":0.00251,"preHourTrading":{"tag":"盘前","latestPrice":576,"preClose":572.38,"latestTime":"09:22 EDT","volume":218,"amount":125509.9684,"timestamp":1715001748096},"postHourTrading":{"tag":"盘后","latestPrice":572.38,"preClose":572.38,"latestTime":"19:50 EDT","volume":235022,"amount":134522008.7165,"timestamp":1714780205346},"volumeRatio":0.485167},"requestUrl":"/m/hq/s/TMO","defaultTab":"news","newsList":[{"id":"2432467967","title":"手术设备需求强劲,百通迪金森上调利润预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432467967","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432467967?lang=zh_cn&edition=full","pubTime":"2024-05-02 19:25","pubTimestamp":1714649144,"startTime":"0","endTime":"0","summary":" 路透5月2日 - 拜登迪金森 周四上调了全年利润预期,第二季度利润超过预期,因为该集团依靠的是对其手术设备和注射器的强劲需求。提供手术和重症监护设备的介入部门本季度的销售额为 12.9 亿美元,高于预期的 11.9 亿美元。集团总收入同比增长 4.6%,达到 50.5 亿美元,略高于预期的 50.4 亿美元。截至3月31日的第二季度,Becton公司调整后每股利润为3.17美元,高于分析师预计的每股2.97美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432044522","title":"生物技术产品需求改善,Bio-Techne 第三季度业绩超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432044522","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432044522?lang=zh_cn&edition=full","pubTime":"2024-05-01 19:29","pubTimestamp":1714562984,"startTime":"0","endTime":"0","summary":"不过,该公司补充说,由于中国的通胀和利率似乎已趋于稳定,预计未来的不利因素将有所缓解。规模较大的同行赛默飞世尔 在财报后的电话会议上表示,生物技术融资环境正在持续改善,部分原因是中国宣布了一项刺激计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430267634","title":"巴克莱:维持Thermo Fisher Scientific(TMO.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430267634","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430267634?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:31","pubTimestamp":1714091499,"startTime":"0","endTime":"0","summary":"巴克莱:维持Thermo Fisher Scientific(TMO.US)评级,由持股观望调整至持股观望评级,目标价由590.00美元调整至615.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260847258b54cf6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260847258b54cf6e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430239988","title":"赛默飞世尔2024财年第一财季实现净利润13.35亿美元,同比增加3.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430239988","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430239988?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:13","pubTimestamp":1714061600,"startTime":"0","endTime":"0","summary":"3月31日,赛默飞世尔公布财报,公告显示公司2024财年第一财季净利润为13.35亿美元,同比增加3.57%;其中营业收入为103.45亿美元,同比减少3.41%,每股基本收益为3.48美元。从资产负债表来看,赛默飞世尔总负债514.72亿美元,其中短期债务44.51亿美元,资产负债比为1.89,流动比率为1.70。机构评级:截至2024年3月31日,当前有23家机构对赛默飞世尔目标价做出预测,其中目标均价为619.07美元,其中最低目标价为540.00美元,最高目标价为670.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260013248b53b0ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260013248b53b0ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430406837","title":"BUZZ-街景:赛默飞 2024 年的 \"设置看起来不错","url":"https://stock-news.laohu8.com/highlight/detail?id=2430406837","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430406837?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:19","pubTimestamp":1714043993,"startTime":"0","endTime":"0","summary":"** 赛默飞世尔现在预计年度利润为每股21.14美元至22.02美元,而之前预计为每股20.95美元至22美元。** 摩根大通 认为,鉴于积极的市场动态和稳健的第一季度业绩,特别是临床研究服务部门 PPD 和生物生产部门的业绩,该公司 2024 年的前景似乎 \"保守\"。** 加拿大皇家银行资本市场 称,TMO上调了其前景展望的高端,为2024年的业绩增长和上调股价奠定了基础","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429430936","title":"BUZZ-赛默飞第一季度利润增长,上调全年利润预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2429430936","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429430936?lang=zh_cn&edition=full","pubTime":"2024-04-24 20:18","pubTimestamp":1713961097,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 4月24日 - ** 医疗设备制造商赛默飞世尔科技公司 股价盘前上涨1.5%至583美元** 该公司将 (link) 年度每股收益预期上调至21.14-22.02美元,此前预期为20.95-22美元。 ** 该公司公布的第一季度每股收益为5.11美元,高于预期的4.71美元。 ** TMO 公布的第一季度收入为 103.5 亿美元,也高于分析师预计的 101.7 亿美元。** 截至最后收盘,该股今年以来基本持平","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429110160","title":"赛默飞世尔盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429110160","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429110160?lang=zh_cn&edition=full","pubTime":"2024-04-24 00:53","pubTimestamp":1713891185,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日00时53分,赛默飞世尔股票出现异动,股价大幅上涨5.01%。截至发稿,该股报575.85美元/股,成交量126.247万股,换手率0.33%,振幅2.83%。赛默飞世尔股票所在的生命科学行业中,整体涨幅为4.80%。赛默飞世尔公司简介:赛默飞世尔科技公司主要销售科学仪器和实验室设备、诊断耗材以及生命科学试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240053057a54f48c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240053057a54f48c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429248009","title":"赛默飞世尔科技公司 预计每股收益4.71美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2429248009","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429248009?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:45","pubTimestamp":1713793509,"startTime":"0","endTime":"0","summary":" * 赛默飞世尔科技公司将于4月24日公布截至2024年3月31日的财报,预计该公司的季度收入将出现下降。 * LSEG 的分析师平均预计赛默飞世尔科技公司的每股收益为 4.71 美元。* 华尔街对赛默飞世尔科技公司 12 个月目标价的中位数为 610.00 美元,高于上一交易日的收盘价 544.78 美元。4月22日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426749243","title":"高盛:维持Thermo Fisher Scientific(TMO.US)评级,由买入调整至买入评级, 目标价由550.00美元调整至640.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426749243","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426749243?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:45","pubTimestamp":1712756719,"startTime":"0","endTime":"0","summary":"高盛:维持Thermo Fisher Scientific(TMO.US)评级,由买入调整至买入评级, 目标价由550.00美元调整至640.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102145238b0a7fc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102145238b0a7fc7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418845537","title":"赛默飞世尔涨0.10% 股价突破600美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2418845537","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418845537?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:33","pubTimestamp":1710250413,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时33分,赛默飞世尔股票出现波动,股价急速上涨0.10%。截至发稿,该股报600.03美元/股,成交量4.9347万股,换手率0.01%,振幅0.57%。赛默飞世尔股票所在的生命科学行业中,整体涨幅为0.03%。赛默飞世尔公司简介:赛默飞世尔科技公司主要销售科学仪器和实验室设备、诊断耗材以及生命科学试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122133337a4bf5b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122133337a4bf5b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417505707","title":"赛默飞世尔涨0.51% 股价突破600美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2417505707","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417505707?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:38","pubTimestamp":1709908689,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时38分,赛默飞世尔股票出现波动,股价急速上涨0.51%。截至发稿,该股报600.70美元/股,成交量15.3293万股,换手率0.04%,振幅0.56%。机构评级方面,在所有26家参与评级的机构中,73%的券商给予买入建议,27%的券商给予持有建议,无券商给予卖出建议。赛默飞世尔股票所在的生命科学行业中,整体涨幅为0.43%。赛默飞世尔公司简介:赛默飞世尔科技公司主要销售科学仪器和实验室设备、诊断耗材以及生命科学试剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822380987e7752d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822380987e7752d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414433703","title":"安捷伦第一季度业绩好于预期,股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2414433703","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414433703?lang=zh_cn&edition=full","pubTime":"2024-02-28 07:55","pubTimestamp":1709078118,"startTime":"0","endTime":"0","summary":" 路透社2月27日 - 安捷伦科技 周二公布的第一季度利润和营收超出华尔街预期,主要得益于其生命科学和诊断部门的强劲销售,股价在盘后交易中上涨了5%。安捷伦生命科学与应用市场部门的收入下降了 10%,降至 8.46 亿美元,但仍高于 7.478 亿美元的预期。这家总部位于加利福尼亚州的公司预计第二季度收入在 15.6 亿美元到 15.9 亿美元之间,而分析师的预期为 16.1 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409403897","title":"药物开发服务需求强劲,沃特世公司第四季度销售额超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2409403897","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409403897?lang=zh_cn&edition=full","pubTime":"2024-02-06 21:12","pubTimestamp":1707225170,"startTime":"0","endTime":"0","summary":" 路透2月6日 - 沃特世公司周二公布的第四季度销售额超过了华尔街的预期,这主要得益于对其用于药物开发的服务的需求。该公司表示,第四季度其主要运营地区中国的销售额与去年同期相比下降了 40%。较大的同行赛默飞世尔科技公司 周三预测的年度利润和收入低于华尔街预期,并表示预计今年中国的需求不会改善。沃特世公布的截至12月31日的季度调整后每股利润为3.62美元,而分析师预计为每股3.55美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408382189","title":"英国反垄断监管机构调查赛默飞世尔收购Olink的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2408382189","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2408382189?lang=zh_cn&edition=full","pubTime":"2024-02-02 23:38","pubTimestamp":1706888333,"startTime":"0","endTime":"0","summary":"英国竞争与市场管理局(CMA)周五表示,正在调查赛默飞世尔科技公司斥资31亿美元收购生物技术公司Olink Holding AB的交易。CMA正在考虑,如果该交易生效,是否会在英国造成实质性的竞争削弱。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:郭明煜","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-02-02/doc-inafsfwc0927072.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2408583609","title":"英国反垄断监管机构调查赛默飞世尔斥资 31 亿美元收购 Olink 的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2408583609","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408583609?lang=zh_cn&edition=full","pubTime":"2024-02-02 19:19","pubTimestamp":1706872768,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透2月2日 - 英国竞争监管机构周五表示,正在调查赛默飞世尔科技公司 斥资31亿美元收购生物技术公司Olink Holding AB 的交易。竞争与市场管理局(CMA) 正在考虑,如果该交易生效,是否会在英国造成实质性的竞争削弱。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408635165","title":"BUZZ-券商观点:尽管前景 \"保守\",赛默飞仍有望在 2024 年实现强劲增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2408635165","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408635165?lang=zh_cn&edition=full","pubTime":"2024-02-01 22:03","pubTimestamp":1706796214,"startTime":"0","endTime":"0","summary":"前景看似保守** Leerink Partners 认为该公司 24 财年前景 \"保守\",并预计在大型制药公司的潜在支持下,其增长将有所改善。** 摩根大通 认为,鉴于该公司在季度业绩和加薪方面的良好记录,今年的财年前景是可以实现的。** TD Cowen 认为该公司的前景似乎比较保守,但下半年的复苏看来是现实的,2024 年的增长将有所改善。** Raymond James 认为 24 财年的指导可能比较保守,在市场动态明朗和经济大幅复苏之前,这是一个坚实的基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408682821","title":"Revvity 2024 年销售额和利润均高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2408682821","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408682821?lang=zh_cn&edition=full","pubTime":"2024-02-01 20:30","pubTimestamp":1706790644,"startTime":"0","endTime":"0","summary":" 路透2月1日 - Revvity 预计全年销售额将超过预期,因为第四季度的需求好于预期,帮助这家医疗设备制造商超过了华尔街的预期。Revvity 预计 2024 年全年总收入将在 27.9 亿美元到 28.5 亿美元之间,高于分析师平均预期的 27.8 亿美元。Revvity第四季度调整后利润为1.25美元,超过分析师预期的1.16美元。Revvity 公司的前身是珀金埃尔默公司,是在母公司 剥离了 三项业务,专注于生命科学和诊断部门 后成立的 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408811266","title":"手术器械强劲增长,百通迪金森上调 2024 年利润预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2408811266","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408811266?lang=zh_cn&edition=full","pubTime":"2024-02-01 20:20","pubTimestamp":1706790043,"startTime":"0","endTime":"0","summary":"根据 LSEG 的数据,第一季度 Becton Dickinson 公司提供手术和重症监护设备的介入部门的销售额为 11.9 亿美元,高于预期的 11.8 亿美元。同时销售针头、注射器和其他此类医疗产品的 Becton Dickinson 公司,调整后每股利润为 2.68 美元,超过了分析师预计的每股 2.40 美元。经调整后,这家总部位于新泽西州的公司目前预计 2024 财年的每股收益将在 12.82 美元至 13.06 美元之间,高于此前预测的每股 12.70 美元至 13.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408517483","title":"赛默飞世尔2023财年实现净利润59.95亿美元,同比减少13.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408517483","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408517483?lang=zh_cn&edition=full","pubTime":"2024-02-01 08:20","pubTimestamp":1706746806,"startTime":"0","endTime":"0","summary":"12月31日,赛默飞世尔公布财报,公告显示公司2023财年净利润为59.95亿美元,同比减少13.74%;其中营业收入为428.57亿美元,同比减少4.58%,每股基本收益为15.53美元。从资产负债表来看,赛默飞世尔总负债518.84亿美元,其中短期债务36.09亿美元,资产负债比为1.91,流动比率为1.76。机构评级:截至2023年12月31日,当前有22家机构对赛默飞世尔目标价做出预测,其中目标均价为570.27美元,其中最低目标价为515.00美元,最高目标价为640.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240201082017815fde6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240201082017815fde6a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408639591","title":"赛默飞世尔盘中异动 临近收盘急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408639591","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408639591?lang=zh_cn&edition=full","pubTime":"2024-02-01 04:51","pubTimestamp":1706734316,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日04时51分,赛默飞世尔股票出现异动,股价急速下跌5.01%。截至发稿,该股报538.73美元/股,成交量269.574万股,换手率0.70%,振幅4.71%。赛默飞世尔股票所在的生命科学行业中,整体跌幅为3.47%。其相关个股中,Trinity Biotech Plc、Volitionrx Limited、Oncocyte Corp涨幅较大,Trinity Biotech Plc、T2 Biosystems Inc、Twist Bioscience Corporation较为活跃,换手率分别为58.38%、1.61%、1.57%,振幅较大的相关个股有Trinity Biotech Plc、Applied Dna Sciences Inc、Dariohealth Corp,振幅分别为36.56%、16.60%、12.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020104515687e6aada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020104515687e6aada&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.thermofisher.com","stockEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0063},{"period":"3month","weight":0.0373},{"period":"6month","weight":0.2587},{"period":"1year","weight":0.049},{"period":"ytd","weight":0.0784}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"赛默飞世尔科技公司是一家特拉华州公司。该公司在为科学服务方面处于世界领先地位。该公司的使命是让客户让世界变得更健康、更清洁、更安全。该公司为在制药和生物技术公司、医院和临床诊断实验室、大学、研究机构和政府机构以及环境、工业、研发、质量和过程控制环境中工作的客户提供服务。该公司的全球团队通过行业领先品牌,包括Thermo Scientific、Applied Biosystems、Invitrogen、Fisher Scientific、Unity Lab Services、Patheon和PPD,提供无与伦比的创新技术、购买便利和制药服务组合。","yearOnYearQuotes":[{"month":1,"riseRate":0.568182,"avgChangeRate":0.027464},{"month":2,"riseRate":0.545455,"avgChangeRate":0.005527},{"month":3,"riseRate":0.545455,"avgChangeRate":0.004275},{"month":4,"riseRate":0.622222,"avgChangeRate":0.040835},{"month":5,"riseRate":0.622222,"avgChangeRate":0.017007},{"month":6,"riseRate":0.409091,"avgChangeRate":0.004109},{"month":7,"riseRate":0.613636,"avgChangeRate":0.007849},{"month":8,"riseRate":0.613636,"avgChangeRate":0.02186},{"month":9,"riseRate":0.568182,"avgChangeRate":-0.009753},{"month":10,"riseRate":0.545455,"avgChangeRate":0.005746},{"month":11,"riseRate":0.5,"avgChangeRate":0.013629},{"month":12,"riseRate":0.613636,"avgChangeRate":0.023246}],"exchange":"NYSE","name":"赛默飞世尔","nameEN":"Thermo Fisher Scientific"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛默飞世尔(TMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛默飞世尔(TMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛默飞世尔,TMO,赛默飞世尔股票,赛默飞世尔股票老虎,赛默飞世尔股票老虎国际,赛默飞世尔行情,赛默飞世尔股票行情,赛默飞世尔股价,赛默飞世尔股市,赛默飞世尔股票价格,赛默飞世尔股票交易,赛默飞世尔股票购买,赛默飞世尔股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛默飞世尔(TMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛默飞世尔(TMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}